Table 1.
Presented are demographic data of all study participants (mean ± SD)
| Studies | 300 µg i.v. G-CSF |
5 µg/kg G-CSF |
Placebo | p value |
|---|---|---|---|---|
| Baseline data | ||||
| Gender m/f | 9/9 | 15/12 | 1/5 | 0.32 |
| Age (years) | 30 ± 2 | 29 ± 1 | 26 ± 2 | 0.57 |
| Height (cm) | 171 ± 2 | 173 ± 2 | 168 ± 3 | 0.34 |
| Weight (kg) | 69 ± 3 | 70 ± 2 | 63 ± 7 | 0.43 |
| Body mass index (kg/m2) | 23.8 ± 0.8 | 23.3 ± 0.8 | 22 ± 1.6 | 0.76 |
| Neutrophil count (G/L) | 3.2 ± 0.3 | 3.0 ± 0.2 | 3.5 ± 0.2 | 0.28 |
| Platelet count (G/L) | 228 ± 12 | 229 ± 11 | 244 ± 17 | 0.62 |
| C-reactive protein (mg/dl) | 0.2 ± 0.1 | 0.4 ± 0.2 | 0.2 ± 0.1 | 0.50 |
No significant differences were found between groups
All values are presented as mean ± SEM, and p values are the results of nonparametric tests